Society for Basic Urologic Research/Society of Urologic Oncology (SBUR/SUO)

Saturday, May 16, 2026 8:00 AM to 12:00 PM · 4 hr. (America/New_York)

202A

Specialty Society

Basic Science ResearchOncology: General

Information

Learning Objectives:

1. Discuss the latest advances in novel therapeutics in urologic cancer, as well as in genomics and tumor subtyping, and their anticipated responses to precision medicine.
2. Utilize knowledge from genomic, pathologic, and bioinformatic studies and data to inspire new ideas and initiatives for urologic cancer research and treatment.
3. Utilize knowledge from global oncology to inspire new ideas and initiatives to address racial disparity in urologic cancer management.

Of Interest To

Researchers

Continuing Medical Education

CME

Society for Basic Urologic Research/Society of Urologic Oncology (SBUR/SUO)

Information

Saturday, May 16

Welcome and Opening Remarks

SESSION 1: Bladder Cancer

The Hidden Memory of DNA Damage: DASP in Bladder Cancer Evolution and Resistance

Bladder Preservation with Systemic Therapy

The Sex-dependent Selection Pressures of Bladder Tumor Evolution

Audience Q&A

SESSION 2: Renal Cell Carcinoma

Liquid Precision: Extracellular Vesicle RNA as the Next Frontier in Urologic Diagnosis

Friend or Foe: TRAIL in VHL-Deficient Renal Cell Carcinoma

Audience Q&A

Break

SESSION 3: Prostate Cancer

Targeting Drivers of Therapy Resistance and Lineage Plasticity in Prostate Cancer

Non-Neuroendocrine Lineage Plasticity in Prostate Cancer

From Mechanism to Therapy: Targeting Transcriptional and Metabolic Adaptation in Advanced Prostate Cancer

Audience Q&A

Donald S. Coffey Lecture: Unraveling Gene Fusions in Solid Tumors: Pathways to Precision Oncology

Closing Remarks

Registered attendees

Log in